Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost €15.00 Clinical safety and efficacy of the first-in-class Rho kinase inhibitor for lowering IOP: netarsudil and the fixed-dose combination of netarsudil and latanoprost quantity Add to cart Category: Articles Tag: Volume 3 Description Description Authors: Janet B. Serle, Jake Radell Related products The microenvironment of subconjunctival tissue after glaucoma filtration surgery €15.00 Add to cart Medical device basics €15.00 Add to cart Novel surgical methods for addressing glaucoma €15.00 Add to cart Cerebrospinal fluid dynamics and primary open-angle glaucoma €15.00 Add to cart